Indications
Treatment of patients with moderate to severe Alzheimer’s disease.
Composition
- Active substance
- memantine
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Nemdatine
- Active substance
- memantine
- ATC code
- N06DX01
- Group
- Nervous system
- Therapeutic area
- Alzheimer Disease
- Marketing authorisation holder
- Actavis Group PTC ehf
- Status
- Authorised
- EU authorisation
- 22 Apr 2013
- Refused
- 22 Feb 2013
- EMA product number